0001971857-24-000412.txt : 20240617 0001971857-24-000412.hdr.sgml : 20240617 20240617134617 ACCESSION NUMBER: 0001971857-24-000412 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240617 DATE AS OF CHANGE: 20240617 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BioXcel Therapeutics, Inc. CENTRAL INDEX KEY: 0001720893 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821386754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38410 FILM NUMBER: 241047668 BUSINESS ADDRESS: STREET 1: 555 LONG WHARF DRIVE CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-643-8060 MAIL ADDRESS: STREET 1: 555 LONG WHARF DRIVE CITY: NEW HAVEN STATE: CT ZIP: 06511 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Yocca Frank CENTRAL INDEX KEY: 0001733272 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 780 EAST MAIN STREET STREET 2: C/O BIOXCEL THERAPEUTICS, INC. CITY: BRANFORD STATE: CT ZIP: 06405 144 1 primary_doc.xml 144 0001733272 XXXXXXXX LIVE 0001720893 BioXcel Therapeutics, Inc. 001-38410 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060 Yocca Frank Officer Common Merrill Lynch

500 Cummings Center Suite 1600 Beverly MA 01915

372 476.16 37530821 06/17/2024 NASDAQ Common 06/14/2024 Restricted Stock Units BioXcel Therapeutics N 521 06/17/2024 Cash Common 06/15/2024 Restricted Stock Units BioXcel Therapeutics N 562 06/17/2024 Cash N Frank Yocca

555 Long Wharf Drive New Haven CT 06511

Common 04/04/2024 1067 2803.48 06/17/2024 12/14/2023 Frank Yocca